Condition

Recurrent Breast Cancer

ClinicalTrials.gov condition label

Clinical trials139
Recruiting4
Common interventions25
Lead sponsors shown15

Clinical trials

60 shown
Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast CancerNCT06900647 · 2025-01-01
RECRUITING
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast CancerNCT06369285 · 2024-11-19
RECRUITING
A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.NCT06202118 · 2024-02-19
RECRUITING
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast CancerNCT06202261 · 2023-04-13
RECRUITING
Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast CancerNCT06329089 · 2024-01-01
UNKNOWN
A Biomarker Screening Protocol for Participants With Solid TumorsNCT05891197 · 2023-05-19
TERMINATED
A Study to Investigate LYL797 in Adults With Solid TumorsNCT05274451 · 2022-03-29
TERMINATED
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast CancerNCT06570031 · 2021-11-09
COMPLETED
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerNCT04360941 · 2020-08-11
ACTIVE_NOT_RECRUITING
B002 in Patients With HER2-positive Breast CancerNCT04382352 · 2019-05-28
COMPLETED
ModraDoc006/r in Patients With Breast CancerNCT03890744 · 2019-01-30
COMPLETED
T-DM1 and Palbociclib for Metastatic HER2 Breast CancerNCT03530696 · 2018-12-06
COMPLETED
Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast CancerNCT03750396 · 2018-08-01
UNKNOWN
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneNCT03602079 · 2018-07-16
COMPLETED
Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation TestingNCT03475979 · 2018-05-01
UNKNOWN
Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerNCT02843126 · 2016-07-01
COMPLETED
2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast CancerNCT02624700 · 2016-01-28
TERMINATED
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast CancerNCT02203552 · 2015-06-23
COMPLETED
Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast CancerNCT02390427 · 2015-04-20
COMPLETED
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast CancerNCT02226276 · 2015-01-07
ACTIVE_NOT_RECRUITING
Phase II Study of Everolimus Beyond ProgressionNCT02269670 · 2014-11-25
TERMINATED
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerNCT02273752 · 2014-11-01
TERMINATED
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving EverolimusNCT02015559 · 2014-10-08
COMPLETED
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or LungNCT01741597 · 2014-07-01
WITHDRAWN
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxNCT02038010 · 2014-05-21
COMPLETED
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerNCT02060253 · 2014-04-01
COMPLETED
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerNCT01938833 · 2014-04-01
TERMINATED
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryNCT01953588 · 2014-02-27
ACTIVE_NOT_RECRUITING
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory BrcaNCT02041429 · 2014-02-01
COMPLETED
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast CancerNCT01712815 · 2013-11-22
TERMINATED
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast CancerNCT01986569 · 2013-11-01
COMPLETED
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerNCT02046421 · 2013-11-01
COMPLETED
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionNCT01249443 · 2013-11-01
TERMINATED
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)NCT01881230 · 2013-09-26
COMPLETED
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsNCT01987726 · 2013-09-03
COMPLETED
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast CancerNCT01918306 · 2013-09-01
TERMINATED
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast CancerNCT01873833 · 2013-07-29
TERMINATED
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerNCT01730833 · 2013-07-17
COMPLETED
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast CancerNCT01868503 · 2013-07-01
TERMINATED
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS MetastasisNCT01783756 · 2013-06-26
COMPLETED
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)NCT01824836 · 2013-06-11
ACTIVE_NOT_RECRUITING
Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast CancerNCT01876238 · 2013-05-01
COMPLETED
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerNCT01791478 · 2013-04-01
COMPLETED
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyNCT01819233 · 2013-03-08
COMPLETED
Cabergoline in Metastatic Breast CancerNCT01730729 · 2013-02-11
COMPLETED
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesNCT01939483 · 2012-12-01
WITHDRAWN
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast CancerNCT01729884 · 2012-12-01
TERMINATED
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone TherapyNCT01720602 · 2012-11-01
COMPLETED
Phase I: At-Home Support for Rural Women Using Group Video CallingNCT01672684 · 2012-10-01
COMPLETED
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryNCT01705340 · 2012-09-01
TERMINATED
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After SurgeryNCT01483196 · 2012-01-01
COMPLETED
BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast CancerNCT01339442 · 2011-11-14
COMPLETED
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast CancerNCT01493310 · 2011-11-01
COMPLETED
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or LetrozoleNCT01478477 · 2011-10-04
COMPLETED
Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin MetastasesNCT01421017 · 2011-08-19
COMPLETED
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerNCT01394211 · 2011-07-13
TERMINATED
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast CancerNCT01355393 · 2011-07-01
COMPLETED
Circulating miRNAs.NCT01722851 · 2011-05-01
COMPLETED
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerNCT00992602 · 2011-04-01
COMPLETED
A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast CancerNCT01351597 · 2011-04-01
UNKNOWN

Common interventions

laboratory biomarker analysisOTHER60pharmacological studyOTHER18trastuzumabBIOLOGICAL14PaclitaxelDRUG9quality-of-life assessmentPROCEDURE9anastrozoleDRUG8capecitabineDRUG6carboplatinDRUG6lapatinib ditosylateDRUG6letrozoleDRUG6questionnaire administrationOTHER6vorinostatDRUG6cyclophosphamideDRUG5fulvestrantDRUG5trastuzumabDRUG5ixabepiloneDRUG4positron emission tomographyPROCEDURE4therapeutic conventional surgeryPROCEDURE4assessment of therapy complicationsPROCEDURE3bevacizumabBIOLOGICAL3everolimusDRUG3exemestaneDRUG3F-18 16 alpha-fluoroestradiolRADIATION3fludeoxyglucose F 18RADIATION3HER-2/neu peptide vaccineBIOLOGICAL3

Trial status mix

COMPLETED91
TERMINATED28
WITHDRAWN7
UNKNOWN5
ACTIVE_NOT_RECRUITING4
RECRUITING4

Phase mix

PHASE273
PHASE153
NA18
PHASE35
EARLY_PHASE11
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.